Clinical Trial Update: Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating Envafolimab alone or in combination with Lenvatinib for advanced endometrial cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Envafolimab (envafolimab)
• Lenvatinib (lenvatinib)

Snippet

Sponsor: 3D Medicines (Sichuan) Co., Ltd. | Conditions: Advanced Endometrial Cancer | Phase 2 | Status: RECRUITING